Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Miyazawa T, Marushima H, Saji H, et al. PD-L1 Expression in non-small-cell lung cancer including various adenocarcinoma subtypes. Ann Thorac Cardiovasc Surg. 2019;25(1):1–9.

    Article  PubMed  Google Scholar 

  2. Zhang C, Zhang J, Xu FP, et al. Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma. J Thorac Oncol. 2019;14(11):1912–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zhou J, Lin H, Ni Z, et al. Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma. BMC Pulm Med. 2023;23(1):18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Yang X, Xiao Y, Hu H, et al. Expression changes in programmed death ligand 1 from precancerous lesions to invasive adenocarcinoma in sub-centimeter pulmonary nodules: a large study of 2022 cases in China. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14009-x.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, South China University of Technology, Guangzhou, China

    Xiongwen Yang MD, PhD & Wen-Zhao Zhong MD, PhD

  2. Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    Xiongwen Yang MD, PhD & Wen-Zhao Zhong MD, PhD

Authors
  1. Xiongwen Yang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wen-Zhao Zhong MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-Zhao Zhong MD, PhD.

Ethics declarations

Disclosure

This work was supported by the National Natural Science Foundation of China (81872510); Guangdong Provincial People’s Hospital Young Talent Project (GDPPHYTP201902); High-level Hospital Construction Project (DFJH201801); GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province (no. KJ012019449); and Guangdong Basic and Applied Basic Research Foundation (no. 2019B1515130002).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, X., Zhong, WZ. ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma. Ann Surg Oncol 30, 7499–7500 (2023). https://doi.org/10.1245/s10434-023-14012-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14012-2

Search

Navigation